Mawson Infrastructure Group Inc. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mawson Infrastructure Group Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Mawson Infrastructure Group Inc. for May 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 09 2018 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | C | 1.31 | 217,442 | 284,414 | 392,055 | |
May 09 2018 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | C | 1.31 | 217,442 | 284,414 | 1,770,802 | 1.6 M to 1.8 M (+14.00 %) |
May 08 2018 | WIZP | Wize Pharma, Inc. | Sadan Simcha | 10% Owner | Option Exercise | X | 1.97 | 144,168 | 284,415 | 114,869 | |
May 08 2018 | WIZP | Wize Pharma, Inc. | Sadan Simcha | 10% Owner | Buy | X | 1.97 | 144,168 | 284,415 | 682,843 | 538.7 K to 682.8 K (+26.76 %) |
May 08 2018 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Option Exercise | C | 1.33 | 213,524 | 284,414 | 94,853 | |
May 08 2018 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Buy | C | 1.33 | 213,524 | 284,414 | 1,394,805 | 1.2 M to 1.4 M (+18.08 %) |
May 01 2018 | WIZP | Wize Pharma, Inc. | Keret Yosef | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Zarzewsky Joseph | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Mayron Ron | Director | Option Exercise | A | 3.59 | 46,500 | 166,935 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Mayron Ron | Director | Grant | A | 0.00 | 40,000 | 0 | 66,259 | 26.3 K to 66.3 K (+152.33 %) |
May 01 2018 | WIZP | Wize Pharma, Inc. | Eisenberg Or | Acting CEO, CFO, Tr ... | Option Exercise | A | 3.59 | 36,000 | 129,240 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Eisenberg Or | Acting CEO, CFO, Tr ... | Grant | A | 0.00 | 40,100 | 0 | 40,100 | 0 to 40.1 K |
May 01 2018 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Operating Off ... | Option Exercise | A | 3.59 | 36,000 | 129,240 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Operating Off ... | Grant | A | 0.00 | 40,100 | 0 | 98,515 | 58.4 K to 98.5 K (+68.65 %) |
May 01 2018 | WIZP | Wize Pharma, Inc. | Franck Amouyal | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 |